Insider · CIK 0001228684
William J Link Phd
Files at RXST (RxSight, Inc.), LNSR (LENSAR, Inc.), TARS (Tarsus Pharmaceuticals, Inc.). First filing Sep 10, 2025, latest Sep 17, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TARS: Tarsus Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | Tarsus Pharmaceuticals, Inc. | $980k 12,500 shares | -12% | - | |
| 45Moderate | TARSsell Tarsus Pharmaceuticals, Inc. | $1.5M 27,116 shares | -16% | +83% from low-3% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Common Stock10b5-1 | +201 | - | - | 106,987 | 25 d ago |
| Sep 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -11,675 | $78.33 | $915k | 95,312 | 25 d ago |
| Sep 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -759 | $79.00 | $60k | 94,553 | 25 d ago |
| Sep 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -66 | $80.01 | $5,281 | 94,487 | 25 d ago |
| Sep 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -201 | $0.00 | $0 | 605 | 25 d ago |
| Sep 16, 2025 | TARS Tarsus Pharmaceuticals, Inc. | GGift Common Stock | -2,000 | $0.00 | $0 | 141,332 | Sep 18, 2025 |
| Sep 8, 2025 | TARS Tarsus Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -27,116 | $57.00 | $1.5M | 143,332 | Sep 10, 2025 |
| Jun 13, 2025 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Common Stock | +3,350 | - | - | 170,448 | Jun 16, 2025 |
| Jun 12, 2025 | TARS Tarsus Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +4,540 | $0.00 | $0 | 4,540 | Jun 16, 2025 |
| Jun 12, 2025 | TARS Tarsus Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +2,954 | $0.00 | $0 | 2,954 | Jun 16, 2025 |
| Jun 13, 2025 | TARS Tarsus Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -3,350 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 3, 2025 | RXST RxSight, Inc. | AGrant or award Common Stock | +10,752 | - | - | 37,855 | Jun 4, 2025 |
| May 23, 2025 | LNSR LENSAR, Inc. | AGrant or award Common Stock | +7,374 | $0.00 | $0 | 550,641 | May 28, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.